GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SillaJen Inc (XKRX:215600) » Definitions » Deferred Tax

SillaJen (XKRX:215600) Deferred Tax : ₩53 Mil (TTM As of Mar. 2025)


View and export this data going back to 2016. Start your Free Trial

What is SillaJen Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

SillaJen's change in deferred tax for the three months ended in Mar. 2025 was ₩1 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Mar. 2025 was ₩53 Mil.

SillaJen Deferred Tax Historical Data

The historical data trend for SillaJen's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SillaJen Deferred Tax Chart

SillaJen Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Deferred Tax
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -6,468.79 691.67 188.00 84.64

SillaJen Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Deferred Tax Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 32.54 7.43 18.53 26.14 1.23

SillaJen Deferred Tax Calculation

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Deferred Tax for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩53 Mil.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SillaJen Deferred Tax Related Terms

Thank you for viewing the detailed overview of SillaJen's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

SillaJen Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SillaJen Inc (XKRX:215600) » Definitions » Deferred Tax
Comparable Companies
XKRX:115180 XKRX:372320 XKRX:064550 XKRX:475960 XKRX:397030 XKRX:389650 XKRX:048410 XKRX:228760 XKRX:053030 XKRX:334970 VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
6F, 252, Geumjeong-ro, Geumjeong-gu, Busan, KOR, 46274
Website
http://www.sillajen.com
SillaJen Inc is a Korean based biotechnology company focused on engineering and developing cancer treatment cells. The company along with its subsidiary SillaJen Biotherapeutics, Inc offers Pexa-Vec, an oncolytic virus with antibodies, and improved survival in a randomized trial to cure cancer; and JX929, an engineered vaccinia virus strain that acts on cancer cells by viral attack and subsequent cancer cell oncolysis. SillaJen operates its business activities in Korea and United States.

SillaJen Headlines

No Headlines